AVM
Arch Venture Management Portfolio holdings
AUM
$299M
This Quarter Return
+7.53%
1 Year Return
-19.47%
3 Year Return
-31.35%
5 Year Return
–
10 Year Return
–
AUM
$162M
AUM Growth
+$162M
(-22%)
Cap. Flow
-$64.4M
Cap. Flow
% of AUM
-39.74%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
8
New
–
Increased
–
Reduced
1
Closed
2
Top Buys
No buys this quarter
Top Sells
| 1 |
Denali Therapeutics
DNLI
|
$55.3M |
| 2 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
$5.45M |
| 3 |
Natera
NTRA
|
$3.58M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
EQRX
1
DELISTED
EQRx, Inc. Common Stock
EQRX
| $67.6M | 41.73% | 36,335,375 | – | – |
|
|
VERV
2
DELISTED
Verve Therapeutics
VERV
| $37.7M | 23.26% | 2,008,809 | – | – |
|
3
Erasca
ERAS
$445M
| $30.5M | 18.84% | 11,055,554 | – | – |
|
|
4
Denali Therapeutics
DNLI
$2.23B
| $20.5M | 12.64% | 693,749 -1,875,000 | -73% | -$55.3M |
|
|
OMIC
5
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
| $3.15M | 1.95% | 3,798,926 | – | – |
|
|
UBX
6
DELISTED
Unity Biotechnology
UBX
| $2.56M | 1.58% | 1,004,817 | – | – |
|
|
7
Natera
NTRA
$23.1B
| – | – | -64,441 | Closed | -$3.58M |
|
|
KRTX
8
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| – | – | -30,000 | Closed | -$5.45M |
|